Melaka, Malaysia – Mahkota Medical Centre (Mahkota) is proud to announce its official recognition as a Finalist for the Flagship Medical Tourism Hospital (FMTH) 2025 Programme. In addition, the hospital has been honoured with a specialised domain-specific award, “Strategic Industry Partnership Leader,” acknowledging its pioneering role in building impactful collaborations across the healthcare ecosystem and the wider tourism industry.

This achievement highlights Mahkota’s leadership in strengthening cross-industry partnerships, elevating patient experience, and contributing to Malaysia’s growing reputation as a leading global healthcare travel destination.

Hospital Background

Established in 1994, Mahkota Medical Centre is one of the largest and most comprehensive tertiary private hospitals in Southern Malaysia. As Melaka’s first JCI-accredited hospital and Malaysia’s first JCI-certified Clinical Care Programme provider for both its Breast Cancer and Chronic Kidney Disease management, Mahkota continues to deliver care that meets the highest international standards of safety, quality, and clinical excellence.

With over 105 full-time specialists across 47 medical disciplines, the hospital offers a full continuum of care,from prevention and diagnostics to treatment, rehabilitation, and recovery. Its Centres of Excellence feature advanced medical technologies, including:

• State-of-the-art cancer diagnostic and therapeutic equipment
• Malaysia’s first adoption of Japan’s leading robotic-assisted surgical system
• The nation’s only High Intensity Focused Ultrasound (HIFU) for women’s health

These innovations reinforce Mahkota’s position as a trusted destination for international patients seeking world-class care with the warmth of Malaysian hospitality.

Advancement Through the FMTH Programme

Participation in the Flagship Medical Tourism Hospital (FMTH) Programme 2023–2025 has accelerated Mahkota’s journey toward becoming a regional centre of excellence. Through the programme, the hospital has:

• Strengthened clinical governance
• Invested in new technologies and specialist capabilities
• Enhanced end-to-end patient experience through digital transformation
• Expanded international patient concierge and care navigation services

The recent launch of Mahkota’s Next Generation Smart Ward underscores the hospital’s commitment to patient-centred innovation. These advancements have attracted more complex oncology, surgical, and interventional cases, while reinforcing Mahkota’s partnerships with medical institutions in Indonesia, Singapore, and across the region.

“The 'Strategic Industry Partnership Leader' award is a powerful validation of our accelerated transformation under the FMTH Programme. We are deeply committed to driving collaboration, technological advancement, and service excellence, ensuring Mahkota remains the trusted destination for world-class treatment and compassionate Malaysian care."

— Ms. Teo Chin Yee, CEO, Mahkota Medical Centre

A Leading Destination for Global Patients

As a Finalist for the FMTH 2025 and recipient of the Strategic Industry Partnership Leader Award, Mahkota Medical Centre continues to set benchmarks in healthcare travel—where global standards, advanced medical innovation, and compassionate care converge in the heart of Melaka.

Mahkota remains committed to delivering exceptional healing experiences to patients from Malaysia, the region, and around the world.